Regeneron to Report First Quarter 2016 Financial and Operating Results and Host Conference Call and Webcast on May 5, 2016
- Nasdaq 100 futures hit record high ahead of business activity data
- Bitcoin (BTC) Recovers to $34,000 as Analysts Insists Crypto Winter Won't Repeat Again
- Cyclical currencies lead after dust settles on Fed
- Xpeng (XPEV) Leaps After Receiving a Green Light From Regulators to Raise Up To $2 Billion in Hong Kong IPO
- 'A Stampede for Clean Energy': Amazon (AMZN) Commits to Buy More Renewable Energy, Becomes the Top All-Time US Corporate Buyer
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
TARRYTOWN, N.Y., April 15, 2016 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its first quarter 2016 financial and operating results on Thursday, May 5, 2016, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day.
Conference Call InformationTo access this call, dial (888) 771-4371 (U.S.) or (847) 585-4405 (International). A link to the webcast may be accessed from the 'Events and Presentations' page of Regeneron's website at www.regeneron.com. A replay of the conference call and webcast will be archived on the Company's website and will be available for 30 days.
About Regeneron Pharmaceuticals, Inc.Regeneron (NASDAQ: REGN) is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for high LDL cholesterol, eye diseases, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including oncology, rheumatoid arthritis, asthma, atopic dermatitis, pain, and infectious diseases. For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.
Manisha Narasimhan, Ph.D.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/regeneron-to-report-first-quarter-2016-financial-and-operating-results-and-host-conference-call-and-webcast-on-may-5-2016-300252054.html
SOURCE Regeneron Pharmaceuticals, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Regeneron to Participate in Guggenheim Biopharma Strategy Series
- Gsport Is Committed To Quality
- Honda Selects Means Industries for Excellence in Quality and Delivery Award from More Than 700 OEM Suppliers
Create E-mail Alert Related CategoriesPress Releases
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!